| scholarly article | Q13442814 |
| P2093 | author name string | Peter J Munson | |
| Sharon M Wahl | |||
| Teresa Greenwell-Wild | |||
| Wenwen Jin | |||
| Zoila Rangel | |||
| Nancy Vázquez | |||
| P2860 | cites work | The interferon response inhibits HIV particle production by induction of TRIM22 | Q21131598 |
| CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract | Q22242965 | ||
| Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract | Q22242981 | ||
| WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 | Q24307411 | ||
| Antiviral actions of interferons | Q24550676 | ||
| TRIM family proteins and their emerging roles in innate immunity | Q24607229 | ||
| Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity | Q24677778 | ||
| Secretory Leukocyte Protease Inhibitor Binds to Annexin II, a Cofactor for Macrophage HIV-1 Infection | Q27485184 | ||
| IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells | Q28214882 | ||
| Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro | Q28293679 | ||
| Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu | Q29547836 | ||
| The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein | Q29619540 | ||
| HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation | Q33359564 | ||
| Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation | Q33707301 | ||
| Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. | Q34335062 | ||
| HIV entry inhibitors. | Q34654433 | ||
| Viral and host cofactors facilitate HIV-1 replication in macrophages | Q35213767 | ||
| Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27. | Q35642774 | ||
| Understanding the pro- and anti-inflammatory properties of IL-27. | Q35829406 | ||
| Adenosine A2a receptors induce heterologous desensitization of chemokine receptors | Q35849780 | ||
| Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression | Q35850696 | ||
| HIV accomplices and adversaries in macrophage infection | Q36565458 | ||
| Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs. | Q36578963 | ||
| HIV-1 immunopathogenesis: how good interferon turns bad. | Q36656715 | ||
| The biology and therapeutic potential of interleukin 27. | Q36733744 | ||
| Induction of alpha interferon by human immunodeficiency virus type 1 in human monocyte-macrophage cultures | Q36822798 | ||
| An update in the development of HIV entry inhibitors | Q36879432 | ||
| Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response | Q36913335 | ||
| Non-conventional signal transduction by type 1 interferons: the NF-kappaB pathway | Q36957641 | ||
| Adenosine A2A receptors and brain injury: broad spectrum of neuroprotection, multifaceted actions and "fine tuning" modulation | Q37006843 | ||
| The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements | Q37096085 | ||
| Rapid myeloid cell transcriptional and proteomic responses to periodontopathogenic Porphyromonas gingivalis | Q37164554 | ||
| Cellular reservoirs of HIV-1 and their role in viral persistence | Q37196089 | ||
| Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction | Q38971294 | ||
| Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. | Q40224822 | ||
| Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. | Q40395336 | ||
| An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells | Q40517735 | ||
| APOBEC-mediated editing of viral RNA. | Q40529937 | ||
| Lecithinized superoxide dismutase: an inhibitor of human immunodeficiency virus replication | Q41124430 | ||
| Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells | Q42799017 | ||
| Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients | Q43040277 | ||
| IFN-alpha regulates Toll-like receptor-mediated IL-27 gene expression in human macrophages | Q43941711 | ||
| IL-27, a novel anti-HIV cytokine, activates multiple interferon-inducible genes in macrophages | Q48019121 | ||
| IL-27 and IFN-αSignal via Stat1 and Stat3 and Induce T-Bet and IL-12Rβ2 in Naive T Cells | Q50335939 | ||
| IFN-beta modulates the response to TLR stimulation in human DC: involvement of IFN regulatory factor-1 (IRF-1) in IL-27 gene expression | Q54431573 | ||
| Macrophages as a source of HIV during opportunistic infections | Q73427586 | ||
| The macrophage origin of the HIV-expressing multinucleated giant cells in hyperplastic tonsils and adenoids | Q77882766 | ||
| Stimulation of cell surface CCR5 and CD40 molecules by their ligands or by HSP70 up-regulates APOBEC3G expression in CD4(+) T cells and dendritic cells | Q79609733 | ||
| Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system | Q80102518 | ||
| IL-27 synthesis induced by TLR ligation critically depends on IFN regulatory factor 3 | Q80427885 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| HIV | Q15787 | ||
| P304 | page(s) | 1864-1874 | |
| P577 | publication date | 2009-06-25 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Interleukin-27 inhibition of HIV-1 involves an intermediate induction of type I interferon | |
| P478 | volume | 114 |
| Q34009882 | A novel role for Slit2/Robo1 axis in modulating HIV-1 replication in T cells |
| Q21131084 | AID and APOBECs span the gap between innate and adaptive immunity |
| Q34461242 | Analytical assessment of interleukin - 23 and -27 cytokines in healthy people and patients with hepatitis C virus infection (genotypes 1 and 3a) |
| Q64279721 | Association of interleukin-27 gene polymorphisms with susceptibility to HIV infection and disease progression |
| Q40279352 | BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity |
| Q33730835 | CD56+ T cells inhibit HIV-1 infection of macrophages |
| Q35242525 | Chitinases in the salivary glands and circulation of patients with Sjögren's syndrome: Macrophage harbingers of disease severity |
| Q99605551 | Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases |
| Q35684549 | Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines in vivo |
| Q39727068 | Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner |
| Q35041156 | Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation |
| Q37365279 | Evaluating the potential of IL-27 as a novel therapeutic agent in HIV-1 infection |
| Q36633351 | Gene therapy using IL-27 ameliorates Sjögren's syndrome-like autoimmune exocrinopathy |
| Q33713794 | Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients |
| Q52642797 | IL-27 Expression and Responsiveness in Human Uterine Epithelial Cells and Fibroblasts In Vitro and the Role of Estradiol |
| Q36463634 | IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. |
| Q36694200 | IL-27 inhibits HIV-1 infection in human macrophages by down-regulating host factor SPTBN1 during monocyte to macrophage differentiation |
| Q33795818 | IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination. |
| Q34438335 | IL-27-induced gene expression is downregulated in HIV-infected subjects. |
| Q35170879 | In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans |
| Q35874404 | Influenza A Virus Induces Interleukin-27 through Cyclooxygenase-2 and Protein Kinase A Signaling |
| Q39148436 | Innate immune receptors in skeletal muscle metabolism. |
| Q35634220 | Interferon regulatory factor 7 is a major hub connecting interferon-mediated responses in virus-induced asthma exacerbations in vivo |
| Q33728042 | Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication |
| Q47552023 | Interferons and beyond: Induction of antiretroviral restriction factors |
| Q36929123 | Interleukin-2 inhibits HIV-1 replication in some human T cell lymphotrophic virus-1-infected cell lines via the induction and incorporation of APOBEC3G into the virion |
| Q34634806 | Interleukin-27 is a potent inhibitor of cis HIV-1 replication in monocyte-derived dendritic cells via a type I interferon-independent pathway |
| Q33590441 | Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese |
| Q28385082 | Interleukin-27 treated human macrophages induce the expression of novel microRNAs which may mediate anti-viral properties |
| Q34242185 | Interleukin-27, an anti-HIV-1 cytokine, inhibits replication of hepatitis C virus |
| Q52723506 | Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection |
| Q36585832 | Maintenance of CMV-specific CD8+ T cell responses and the relationship of IL-27 to IFN-γ levels with aging |
| Q92199134 | Mucosal T follicular helper cells in SIV-infected rhesus macaques: contributing role of IL-27 |
| Q90690250 | Murine myeloid-derived suppressor cells are a source of elevated levels of interleukin-27 in early life and compromise control of bacterial infection |
| Q33712080 | Plasma interleukin-27 (IL-27) levels are not modulated in patients with chronic HIV-1 infection |
| Q40621223 | Soluble IL-6 Receptor and IL-27 Subunit p28 Protein Complex Mediate the Antiviral Response through the Type III IFN Pathway |
| Q35197399 | Structural variants of IFNα preferentially promote antiviral functions |
| Q36370053 | Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. |
| Q33810779 | The macrophage in HIV-1 infection: from activation to deactivation? |
| Q33874252 | The mouth: a gateway or a trap for HIV? |
| Q26752737 | The role of BST-2/Tetherin in host protection and disease manifestation |
| Q64971881 | Transcriptional Profiling Suggests Extensive Metabolic Rewiring of Human and Mouse Macrophages during Early Interferon Alpha Responses. |
| Q47552005 | Understanding the regulation of APOBEC3 expression: Current evidence and much to learn. |
Search more.